RoslinCT Revenue
Biotechnology Research • 
Edinburgh, Scotland, United Kingdom • 201-500 Employees
RoslinCT revenue & valuation
| Annual revenue | $4,100,000 |
| Revenue per employee | $10,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $13,200,000 |
| Total funding | No funding |
Key Contact at RoslinCT
Company overview
| Headquarters | Nine Edinburgh BioQuarter, 9 Little France Road, Edinburgh, EH16 4UX, GB |
| Phone number | +441316585180 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Process Development, Gap Analysis, Gmp Manufacture, Cell Banking, Tissue Procurement, Gmp Storage, In-Process And Final Product Qc Testing, Optimisation & Scale-Up, Qp Batch Certification |
| Founded | 2015 |
| Employees | 201-500 |
| Socials |
RoslinCT Email Formats
RoslinCT uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@roslinct.com), used 77.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@roslinct.com | 77.4% |
{first initial}.{last name} | j.doe@roslinct.com | 22.6% |
About RoslinCT
RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell Therapies. Established in 2005 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones, including being among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR-edited stem cell-based therapy for a major disease to marketing authorization. Equipped with 22 purpose-built cGMP cell therapy processing suites in Edinburgh, Scotland, and Hopkinton, Massachusetts, RoslinCT provides innovative process and analytical development, cGMP clinical and commercial manufacturing for a range of cell types for both autologous and allogeneic processes, and cGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, RoslinCT enables partners to efficiently progress from development to commercialization and deliver life-saving Cell and Gene Therapies worldwide. Discover more about our services at www.roslinct.com.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
RoslinCT has 246 employees across 11 departments.
Departments
Number of employees
RoslinCT Tech Stack
Discover the technologies and tools that power RoslinCT's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript graphics
JavaScript libraries
Analytics
Tag managers
Cookie compliance
Programming languages
Miscellaneous
Cookie compliance
JavaScript libraries
Marketing automation
Blogs
Germany
Belgium
Australia
United States
India
Frequently asked questions
4.8
40,000 users
